Building on our earlier findings, which suggest that CD39 + CD8 + T cells may be enriched for cells recognising antigens within the tumour, we investigated whether EGFR-TKI acquired resistance could influence the TCR-Vβ diversity in pleural CD39 + CD8 + T cells. Here, ENTPD1 is linked to neoplasm.